The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer

Abstract Background CT scans are used in routine clinical practice for the diagnosis and treatment surveillance of non‐small cell lung cancer (NSCLC). However, more sensitive methods are desirable. Liquid biopsy analyses of RNA and DNA can offer more sensitive diagnostic approaches. Cell‐free RNA (c...

詳細記述

書誌詳細

主要な著者:	Martin Metzenmacher, Balazs Hegedüs, Jan Forster, Alexander Schramm, Peter A. Horn, Christoph A. Klein, Nicola Bielefeld, Till Ploenes, Clemens Aigner, Jens T. Siveke, Martin Schuler, Smiths S. Lueong
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2022-08-01
シリーズ:	Thoracic Cancer
主題:	cfRNA ddPCR liquid biopsy NGS NSCLC
オンライン･アクセス:	https://doi.org/10.1111/1759-7714.14540
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!